KALA BIO, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving KALA BIO, Inc. now
Current reporting with the operating signal separated from the noise.
KALA Bio, Inc. Announces Leadership Transition with Appointment of Todd Bazemore as Interim CEO
The story matters when it changes KALA BIO, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.KALA BIO, Inc. Secures $10.75 Million in Private Placement to Advance Clinical Development of KPI-012
The story matters when it changes KALA BIO, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest KALA filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
KALA BIO, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →